1,379
Views
1
CrossRef citations to date
0
Altmetric
Review

Use of spacers for patients treated with pressurized metered dose inhalers: focus on the VENTOLIN™ Mini Spacer

, ORCID Icon, &
Pages 419-430 | Received 08 Nov 2017, Accepted 02 Feb 2018, Published online: 12 Feb 2018

References

  • Terzano C. Pressurized metered dose inhalers and add-on devices. Pulm Pharmacol Ther. 2001;14(5):351–366. PubMed PMID: 11603949.
  • Lavorini F, Corrigan CJ, Barnes PJ, et al. Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med. 2011 Jul;105(7):1099–1103. PubMed PMID: 21489771.
  • Pauwels R, Newman S, Borgstrom L. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. Eur Respir J. 1997 Sep;10(9):2127–2138. PubMed PMID: 9311516.
  • Sanders M, Bruin R. A rationale for going back to the future: use of disposable spacers for pressurised metered dose inhalers. Pulm Med. 2015;2015:176194. PubMed PMID: 26491563; PubMed Central PMCID: PMCPMC4600499.
  • Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis Suppl. 1982;119: 101–104. PubMed PMID: 6954081.
  • Price DB, Roman-Rodriguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1071–1081.e9. PubMed PMID: 28286157.
  • Newman SP, Newhouse MT. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med. 1996 Spring;9(1):55–70. PubMed PMID: 10160209.
  • Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Opin Drug Deliv. 2009 Jan;6(1):91–102. PubMed PMID: 19236210.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention. 2017. Available from: http://ginasthmaorg/gina-reports/.
  • O’Callaghan C, Barry PW. How to choose delivery devices for asthma. Arch Dis Child. 2000 Mar;82(3):185–187. PubMed PMID: 10685914; PubMed Central PMCID: PMCPMC1718256.
  • Nikander K, Nicholls C, Denyer J, et al. The evolution of spacers and valved holding chambers. J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(Suppl 1):S4–S23. PubMed PMID: 25054481.
  • Brennan VK, Osman LM, Graham H, et al. True device compliance: the need to consider both competence and contrivance. Respir Med. 2005 Jan;99(1):97–102. PubMed PMID: 15672856.
  • Burgess SW, Sly PD, Cooper DM, et al. Novel spacer device does not improve adherence in childhood asthma. Pediatr Pulmonol. 2007 Aug;42(8):736–739. PubMed PMID: 17588243.
  • Watt PM, Clements B, Devadason SG, et al. Funhaler spacer: improving adherence without compromising delivery. Arch Dis Child. 2003 Jul;88(7):579–581. PubMed PMID: 12818901; PubMed Central PMCID: PMCPMC1763180.
  • Corr D, Dolovich M, McCormack D, et al. Design and characteristics of a portable breath actuated, particle size selective medical aerosol inhaler. J Aerosol Sci. 1982;13(1):1–7.
  • Stein SW, Sheth P, Hodson PD, et al. Advances in metered dose inhaler technology: hardware development. AAPS PharmSciTech. 2014 Apr;15(2):326–338. PubMed PMID: 24357110; PubMed Central PMCID: PMCPMC3969498.
  • Beaucage JMD, Nault D. Using inhalation devices. In: Bourbeau J, editor. Comprehensive management of chronic obstructive pulmonary disease: PMPH-USA. London: BC Decker Inc. 2002.
  • Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003 Dec;56(6):588–599. PubMed PMID: 14616418; PubMed Central PMCID: PMCPMC1884307.
  • Bisgaard H. Delivery of inhaled medication to children.J Asthma. 1997;346:443–467. PubMed PMID: 9428291.
  • Fontana GA, Lavorini F, Chiostri M, et al. Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients. J Aerosol Med. 1999 Fall;12(3):177–185. PubMed PMID: 10623334.
  • Pedersen S. Treatment of acute bronchoconstriction in children with use of a tube spacer aerosol and a dry powder inhaler. Allergy. 1985 May;40(4):300–304. PubMed PMID: 3890600.
  • Tobin MJ, Jenouri G, Danta I, et al. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis. 1982 Oct;126(4):670–675. PubMed PMID: 7125359.
  • Lavorini F, Geri P, Luperini M, et al. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction. Br J Clin Pharmacol. 2004 Nov;58(5):512–520. PubMed PMID: 15521899; PubMed Central PMCID: PMCPMC1884617.
  • Lavorini F, Geri P, Mariani L, et al. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism. Br J Clin Pharmacol. 2006 Oct;62(4):403–411. PubMed PMID: 16995861; PubMed Central PMCID: PMCPMC1885153.
  • Newman SP. Principles of metered-dose inhaler design. Respir Care. 2005 Sep;50(9):1177–1190. PubMed PMID: 16122401.
  • Gabrio BJ, Stein SW, Velasquez DJ. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm. 1999 Sep 10;186(1):3–12. PubMed PMID: 10469919.
  • Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet. 2004;43(6):349–360. PubMed PMID: 15086274.
  • O’Callaghan C, Lynch J, Cant M, et al. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax. 1993 Jun;48(6):603–606. PubMed PMID: 8346488; PubMed Central PMCID: PMCPMC464576.
  • Roller CM, Zhang G, Troedson RG, et al. Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children. Eur Respir J. 2007 Feb;29(2):299–306. PubMed PMID: 17005581.
  • Pedersen S, Dubus JC, Crompton GK, et al. The ADMIT series–issues in inhalation therapy. 5) Inhaler selection in children with asthma. Prim Care Respir J. 2010 Sep;19(3):209–216. PubMed PMID: 20640390.
  • Mitchell JP, Nagel MW. Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim Care Respir J. 2007 Aug;16(4):207–214. PubMed PMID: 17625786.
  • Franklin W, Lowell FC, Michelson AL, et al. Aerosolized steroids in bronchial asthma. J Allergy. 1958 May;29(3):214–221. PubMed PMID: 13538614.
  • Fink JB. Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care. 2000 Jun;45(6):623–635. PubMed PMID: 10894455.
  • Hedrick ND, Hughes AM, Mckeehan PB, et al. Inhalation-responsive aerosol dispenser. Google Patents. 1971.
  • Freigang B. New method of beclomethasone aerosol administration to children under 4 years of age. Can Med Assoc J. 1977 Dec 03;117(11):1308–1309. PubMed PMID: 922624; PubMed Central PMCID: PMCPMC1880346.
  • Moren NFE, Wetterlin KIL. Device for use with medicinal inhalation devices. Google Patents. 1979.
  • Biggart E, Bush A. Antiasthmatic drug delivery in children. Paediatr Drugs. 2002;4(2): 85–93. PubMed PMID: 11888356.
  • Newman SP, Woodman G, Clarke SW, et al. Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract. Chest. 1986 Apr;89(4):551–556. PubMed PMID: 3956281.
  • el-Kassimi FA. "Aerosol-in-bag” administration of inhaled bronchodilators. Eur J Respir Dis. 1987 Apr;70(4):234–238. PubMed PMID: 3582520.
  • Scott SD, Osmond MH, O’Leary KA, et al. Barriers and supports to implementation of MDI/spacer use in nine Canadian pediatric emergency departments: a qualitative study. Implement Sci. 2009 Oct 13;4:65. PubMed PMID: 19828086; PubMed Central PMCID: PMCPMC2766417.
  • Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005 Jan;127(1):335–371. PubMed PMID: 15654001.
  • Levy ML, Hardwell A, McKnight E, et al. Asthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J. 2013 Dec;22(4):406–411. PubMed PMID: 24042172.
  • Vargas O, Martinez J, Ibanez M, et al. The use of metered-dose inhalers in hospital environments. J Aerosol Med Pulm Drug Deliv. 2013 Oct;26(5):287–296. PubMed PMID: 23458577.
  • Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2013 Sep 13;(9):CD000052. PubMed PMID: 24037768.
  • Brown PH, Blundell G, Greening AP, et al. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax. 1990 Oct;45(10):736–739. PubMed PMID: 2247863; PubMed Central PMCID: PMCPMC462716.
  • Farrer M, Francis AJ, Pearce SJ. Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax. 1990 Oct;45(10):740–742. PubMed PMID: 2247864; PubMed Central PMCID: PMCPMC462717.
  • Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1497–1504. PubMed PMID: 16192448.
  • Derom E, Strandgarden K, Schelfhout V, et al. Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD. Respir Med. 2007 Sep;101(9):1931–1941. PubMed PMID: 17544264.
  • Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics. 2001 Aug;108(2):389–394. PubMed PMID: 11483804.
  • Ari AA. Jet, ultrasonic, and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes. Eurasian J Pulmonol. 2014;16:1–7.
  • Fok TF, Lam K, Ng PC, et al. Delivery of salbutamol to nonventilated preterm infants by metered-dose inhaler, jet nebulizer, and ultrasonic nebulizer. Eur Respir J. 1998 Jul;12(1):159–164. PubMed PMID: 9701431.
  • Mason N, Roberts N, Yard N, et al. Nebulisers or spacers for the administration of bronchodilators to those with asthma attending emergency departments? Respir Med. 2008 Jul;102(7):993–998. PubMed PMID: 18396026.
  • Dolovich M. In my opinion—interview with the expert. Pediatr Asthma Allergy Immunol. 2005;17(4):292–300.
  • Taffet GE, Donohue JF, Altman PR. Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging. 2014;9:23–30. PubMed PMID: 24376347; PubMed Central PMCID: PMCPMC3864989.
  • National Institute for Health and Care Excellence. Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years). 2002. [Cited 2017 May 15]. Available from: https://www.nice.org.uk/guidance/ta38/resources/inhaler-devices-for-routine-treatment-of-chronic-asthma-in-older-children-aged-515-years-pdf-2294523372229
  • National Institute for Health and Care Excellence. Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma. 2000. [Cited 2017 May 15] Available from: https://www.nice.org.uk/guidance/ta10/resources/guidance-on-the-use-of-inhaler-systems-devices-in-children-under-the-age-of-5-years-with-chronic-asthma-pdf-2294389002949
  • National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. editor. 2010. [Cited 2017 May 15] Available from: https://www.nice.org.uk/guidance/cg101/resources/chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and-management-pdf-35109323931589
  • GOLD. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2017 [cited 2017 May 15]. Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/.
  • Bonini MU, Omar S. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015;1:9.
  • Ruse C. Current approaches to management of COPD. Prescriber. 2008;19(6):17–20.
  • National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care [Update]. London:National Clinical Guideline Centre. 2010.
  • Moren F. Drug deposition of pressurized inhalation aerosols I. Influence of actuator tube design. Int J Pharm. 1978;1(4):205–212.
  • Barry PW, O’Callaghan C. Inhalational drug delivery from seven different spacer devices. Thorax. 1996 Aug;51(8):835–840. PubMed PMID: 8795674; PubMed Central PMCID: PMCPMC472565.
  • Altounyan REC, Auty RM. Aerosol inhalation device. Google Patents. 1986.
  • Sackner MA, Watson H Drug delivery method and inhalation device therefor. Google Patents. 1984.
  • Mitchell JP, Coppolo DP, Nagel MW. Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices. Respir Care. 2007 Mar;52(3):283–300. PubMed PMID: 17328827.
  • Lulla A, Rao X. Spacer device for inhaler. Google Patents. 2005.
  • Barry PW, O’Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol. 1995 Jul;40(1):76–78. PubMed PMID: 8527272; PubMed Central PMCID: PMCPMC1365031.
  • Anhoj J, Bisgaard H, Lipworth BJ. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children. Br J Clin Pharmacol. 1999 Mar;47(3):333–336. PubMed PMID: 10215759; PubMed Central PMCID: PMCPMC2014226.
  • Pierart F, Wildhaber JH, Vrancken I, et al. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J. 1999 Mar;13(3):673–678. PubMed PMID: 10232445.
  • Wildhaber JH, Devadason SG, Hayden MJ, et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J. 1996 Sep;9(9):1943–1946. PubMed PMID: 8880115.
  • NHS Business Services Authority. Drug Tariff. [updated Jan 2018; cited Jan 2018]. Available from: https://www.nhsbsa.nhs.uk/sites/default/files/2017-12/January%202018.pdf
  • Lipworth BJ, Clark DJ. Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices. Br J Clin Pharmacol. 1998 Jul;46(1):45–48. PubMed PMID: 9690948; PubMed Central PMCID: PMCPMC1873975.
  • Liu X, Guo C, Chowdhury B, et al. Valved holding chambers and in vitro metered dose inhaler performance: effects of flow rate and inhalation delay. J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):399–410. PubMed PMID: 28846482; eng.
  • Ahrens R, Lux C, Bahl T, et al. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient’s need: evidence that the specific drug being delivered is an important consideration. J Allergy Clin Immunol. 1995 Aug;96(2):288–294. PubMed PMID: 7636073.
  • GSK. AeroChamber Plus* GSK2016. [ cited 2017 Jul 8]. Available from: https://hcp.gsk.co.uk/products/aerochamber-plus/product-overview.html
  • Carvalho TC, Peters JI, Williams RO 3rd. Influence of particle size on regional lung deposition–what evidence is there? Int J Pharm. 2011 Mar 15;406(1–2):1–10. PubMed PMID: 21232585.
  • Copley M. Understanding cascade impaction and its importance for inhaler testing. 2007. [Cited 2017 April 17] Available from: http://www.copleyscientific.com/files/ww/articles/Understanding%20Cascade%20Impaction%20White%20Paper.pdf
  • Mehta R, Montembault M, Warren F, et al. Systemic exposures of fluticasone propionate and salmeterol following inhalation via metered dose inhaler with the mini spacer compared with the Aerochamber Plus spacer. J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):386–392. PubMed PMID: 26824933.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.